Our Ligand Trap System allows
cost-effective and high-throughput
in-vivo screening of new chemical
entities targetting the nuclear receptor
learn more about the science
InDanio Bioscience participated at the MaRS HealthKick event on May 15, 2014, and won a placement at the Canadian Technology Accelerator program in Boston.
InDanio Bioscience concludes first agreement with pharmaceutical industry consortium in drug discovery July 4, 2013
In conversation with InDanio Bioscience November 6, 2012
"This week in the biotech twitter verse"
Cross Border Biotech
October 16, 2010
"First inVivo Screening System for complete human nuclear hormone receptor family"
The Medical News
October 20, 2010
The Zebrafish: A Powerful Platform for In Vivo, HTS Drug Discovery
Delvecchio et al.
A Live Zebrafish-Based Screening System for Human Nuclear Receptor Ligand and Cofactor Discovery
Tiefenbach et al.